Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -8.15M | -9.74M | -8.51M | -9.35M | -7.91M |
| Total Depreciation and Amortization | 97.00K | 97.00K | 95.00K | 96.00K | 99.00K |
| Total Amortization of Deferred Charges | 218.00K | 214.00K | 207.00K | 199.00K | 56.00K |
| Total Other Non-Cash Items | 693.00K | 693.00K | 764.00K | 560.00K | 878.00K |
| Change in Net Operating Assets | -655.00K | 968.00K | -1.01M | 1.37M | -70.00K |
| Cash from Operations | -7.80M | -7.77M | -8.45M | -7.13M | -6.95M |
| Capital Expenditure | -3.00K | -31.00K | -47.00K | -15.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.79M | 2.04M | 3.31M | 1.86M | -1.61M |
| Cash from Investing | 3.79M | 2.01M | 3.27M | 1.85M | -1.62M |
| Total Debt Issued | -- | -- | -- | 10.36M | 0.00 |
| Total Debt Repaid | -1.30M | -135.00K | -131.00K | -15.00K | -65.00K |
| Issuance of Common Stock | 0.00 | 19.00K | 2.00K | 10.00K | 17.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -54.00K |
| Cash from Financing | -1.30M | -116.00K | -129.00K | 10.35M | -102.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.31M | -5.88M | -5.32M | 5.08M | -8.67M |